STUDIES ON DNA POLYMERASES
STUDIES ON DNA POLYMERASES
批准号:
8169234
负责人:
ANEEL K. AGGARWAL
金额:
$0.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2011-03-31
关键词:
AdenineBypassCellsChemicalsComputer Retrieval of Information on Scientific Projects DatabaseDNA DamageDNA Repair PathwayDNA biosynthesisDNA-Directed DNA PolymeraseDiseaseEukaryotaFundingGrantHandHumanHydrolysisInheritedInstitutionLesionMalignant NeoplasmsMutationPolymeraseResearchResearch PersonnelResourcesSourceSunlightThymine DimersTissuesTumor Suppressor ProteinsUV inducedUnited States National Institutes of HealthVariantXeroderma Pigmentosumcopingdimeroxidationpollutantrepaired
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
细胞组织不断受到外部阳光和化学污染物以及内部氧化和水解等破坏性因素的影响(Prakash等人,2005年)。各种DNA修复途径已经进化到修复所产生的损伤,但一些损伤逃脱修复,并将遇到复制机制。新发现的跨损伤DNA合成(TLS)聚合酶允许细胞通过损伤促进复制,从而应对未修复的DNA损伤,否则复制叉会停滞。人类有四个这样的TLS聚合酶Pol?和Rev1,每个都有独特的DNA损伤旁路和保真度特征。例如,POL的独特之处在于其通过紫外线诱导的顺式环丁烷胸腺嘧啶-胸腺嘧啶(T-T)二聚体通过插入两个与二聚体相对的腺嘌呤进行复制的熟练能力。人类POL的突变是一种遗传性癌症易感疾病的原因,这种疾病是变种形式的着色性干皮病(XP-V)。因此,POL?是第一个被证明发挥肿瘤抑制作用的DNA聚合酶。另一方面,POL专门研究未受损DNA上错配对的引物末端的延伸,以及病变旁路的延伸步骤。为了了解这些聚合酶如何与“经典”聚合酶交换,我们还启动了对真核生物中领先/滞后链聚合酶的研究。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Cellular tissue is continually subjected to damaging agents such as sunlight and chemical pollutants externally, and oxidation and hydrolysis internally (Prakash et al., 2005). A variety of DNA repair pathways have evolved to repair the resulting lesions, but some lesions escape repair and will be encountered by the replication machinery. The newly discovered translesion DNA synthesis (TLS) polymerases allow cells to cope with unrepaired DNA damage by promoting replication through lesions that would otherwise stall the replication fork. Humans have four such TLS polymerases Pol¿, Pol¿, Pol¿, and Rev1 each with a unique DNA damage bypass and fidelity profile. Pol¿, for example, is unique in its proficient ability to replicate through a UV-induced cis-syn cyclobutane thymine-thymine (T-T) dimer) by inserting two adenines opposite the dimer. Mutations in human Pol¿ are responsible for an inherited cancer-prone disorder, the variant form of xeroderma pigmentosum (XP-V). Pol¿ is, thus, the first DNA polymerase demonstrated to act as a tumor suppressor. Pol¿, on the other hand, is specialized in the extension of mispaired primer termini on undamaged DNAs, and in the extension step of lesion bypass. To understand how these polymerases exchange with "classical" polymerases, we have also initiated studies on the leading/lagging strand polymerases in eukaryotes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of MS2045 for inhibition of Zika methyltransferase
-
批准号:10645958
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2023
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Structure and Specificity of Restriction-Modification (R-M) Systems
-
批准号:10241952
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2019
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Structure and Specificity of Restriction-Modification (R-M) Systems
-
批准号:10470890
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Structure and Specificity of Restriction-Modification (R-M) Systems
-
批准号:10686907
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2019
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Structure and Specificity of Restriction-Modification (R-M) Systems
-
批准号:10797690
-
项目类别:
-
资助金额:$11.79万
-
财政年份:2019
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Structure and Specificity of Restriction-Modification (R-M) Systems
-
批准号:10727038
-
项目类别:
-
资助金额:$9.51万
-
财政年份:2019
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Structure and Specificity of Restriction-Modification (R-M) Systems
-
批准号:10599570
-
项目类别:
-
资助金额:$9.67万
-
财政年份:2019
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Structure and mechanism of multisubunit complexes of DNA polymerase zeta
-
批准号:10249252
-
项目类别:
-
资助金额:$46.36万
-
财政年份:2018
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Structure and mechanism of multisubunit complexes of DNA polymerase zeta
-
批准号:10018049
-
项目类别:
-
资助金额:$46.36万
-
财政年份:2018
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Genome-wide detection of UV DNA damage by single molecule real time sequencing
-
批准号:8807049
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2014
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Structure-function analysis of a molecular switch for long-range diffusion on DNA
-
批准号:8927038
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2014
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Role of human DNA polymerase iota in replicative bypass of DNA lesions
-
批准号:9182819
-
项目类别:
-
资助金额:$44.37万
-
财政年份:2012
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Role of human DNA polymerase iota in replicative bypass of DNA lesions
-
批准号:8762244
-
项目类别:
-
资助金额:$44.37万
-
财政年份:2012
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Role of human DNA polymerase iota in replicative bypass of DNA lesions
-
批准号:8582552
-
项目类别:
-
资助金额:$43.93万
-
财政年份:2012
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Role of human DNA polymerase iota in replicative bypass of DNA lesions
-
批准号:8960856
-
项目类别:
-
资助金额:$44.37万
-
财政年份:2012
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Role of human DNA polymerase iota in replicative bypass of DNA lesions
-
批准号:8435949
-
项目类别:
-
资助金额:$46.11万
-
财政年份:2012
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
RESTRICTION ENDONUCLASE SFII
-
批准号:8363363
-
项目类别:
-
资助金额:$0.25万
-
财政年份:2011
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
STUDIES ON DNA POLYMERASES
-
批准号:8361619
-
项目类别:
-
资助金额:$2.19万
-
财政年份:2011
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
DNA POLYMERASE ETA/DNA/DNTP COCRYSTALS: A LARGE UNIT CELL PROBLEM
-
批准号:8363392
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2011
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
Role of DNA polymerase eta in errorfree bypass of DNA lesions & cancer prevention
-
批准号:8580936
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2010
-
负责人:ANEEL K. AGGARWAL
-
依托单位:
国内基金
海外基金
展向局部自由流湍流下边界层bypass转捩的二次失稳机理的研究
-
批准号:11202147
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2012
-
负责人:张永明
-
依托单位:
边界层中Bypass转捩机理的研究
-
批准号:11102131
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2011
-
负责人:董明
-
依托单位: